Search

Your search keyword '"Gormally, E"' showing total 70 results

Search Constraints

Start Over You searched for: Author "Gormally, E" Remove constraint Author: "Gormally, E"
70 results on '"Gormally, E"'

Search Results

4. Multi-factor dimensionality reduction applied to a large prospective investigation on gene–gene and gene–environment interactions

5. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study

6. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study

7. Erratum: Amount of DNA in plasma and cancer risk: A prospective study (International Journal of Cancer (2004) 111 (746-749))

8. Physical activity and lung cancer among non-smokers: A pilot molecular epidemiological study within EPIC

9. Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective study

10. Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions

11. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study

13. DNA adducts and lung cancer risk: A prospective study

14. Amount of DNA in plasma and cancer risk: A prospective study

15. Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions.

16. DNA adducts and lung cancer risk: a prospective study.

17. Amount of DNA in plasma and cancer risk: a prospective study.

18. Amount of DNA in plasma and cancer risk: a prospective study.

19. Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions

20. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study

22. Refined localization of the Batten disease gene (CLN3) by haplotype and linkage disequilibrium mapping to D16S288-D16S383 and exclusion from this region of a variant form of Batten disease with granular osmiophilic deposits

24. Methodology of laboratory measurements in prospective studies on gene–environment interactions: The experience of GenAir

25. Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective study

26. Amount of DNA in plasma and cancer risk: A prospective study

27. DNA adducts and lung cancer risk: a prospective study

28. TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study

29. Physical activity and lung cancer among non-smokers: a pilot molecular epidemiological study within EPIC

30. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study

31. Environmental tobacco smoke and risk of respiratory cancer andchronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study

32. Valorization of biomass polyphenols as potential tyrosinase inhibitors.

33. First Molecular Characterization of Chronic Hepatitis B Carriers in Timbuktu, Mali.

34. Decrease in liver cancer incidence rates in Bamako, Mali over 28 years of population-based cancer registration (1987-2015).

35. Biobanking Education.

36. Cancer prevention and control: hepatocellular carcinoma.

37. Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

38. Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.

39. Training the Next Generation of Biobankers: A Two-Year Master's Course in the Management of Biobanks.

40. Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali.

41. Breast cancer in pre-menopausal women in West Africa: analysis of temporal trends and evaluation of risk factors associated with reproductive life.

42. Physical activity and lung cancer among non-smokers: a pilot molecular epidemiological study within EPIC.

43. Detection of p53 codon 249 mutation in Nigerian patients with hepatocellular carcinoma using a novel evaluation of cell-free DNA.

44. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance.

45. TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.

46. DNA adducts and lung cancer risk: a prospective study.

47. Molecular detection of early-stage laryngopharyngeal squamous cell carcinomas.

48. Amount of DNA in plasma and cancer risk: a prospective study.

49. Positioning of five genes (CASK, ARX, SAT, IMAGE cDNAs 248928 and 253949) from the human X chromosome short arm with respect to evolutionary breakpoints on the mouse X chromosome.

50. Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. jderry@immunex.com.

Catalog

Books, media, physical & digital resources